Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.335,47
-1,55%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Genuit Group Plc (GEN) Genuit Group Plc (GEN) Notizie

Genuit Group Plc

GEN
438,00
1,50 (0,34%)
01 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
24/4/202411:39LSEG_RNSGenuit Group PLC Notice of AGM
10/4/202417:24LSEG_RNSGenuit Group PLC Director/PDMR Shareholding
10/4/202417:17LSEG_RNSGenuit Group PLC Director/PDMR Shareholding
09/4/202417:28LSEG_RNSGenuit Group PLC Director Declaration
02/4/202416:56LSEG_RNSGenuit Group PLC Director/PDMR Shareholding
20/3/202416:27LSEG_RNSGenuit Group PLC Director/PDMR Shareholding
12/3/202411:40ALNCNewsGenuit revenue drops on lower divisional sales but profit..
12/3/202408:09ALNCNews*Genuit says 2024 trading has started in line w/..
12/3/202408:00LSEG_RNSGenuit Group PLC Final Results
01/3/202409:30LSEG_RNSGenuit Group PLC Director Declaration
19/2/202410:00LSEG_RNSGenuit Group PLC Notice of Results and Investor Presentation
23/1/202416:49UKREGGenuit Group PLC Holding(s) in Company
23/1/202412:24UKREGGenmab A/S Genmab Announces Net Sales Of Darzalex(R)..
23/1/202400:40UKREGGenmab A/S Genmab Announces Decision In Arbitration Appeal..
09/1/202412:45UKREGGenmab A/S Tivdak(R) (tisotumab vedotin-tftv) Supplemental..
03/1/202406:55UKREGGenmab A/S Transactions With Shares And Linked Securities In..
02/1/202415:52UKREGGenmab A/S Genmab To Present At The 42nd Annual J.P. Morgan..
12/12/202313:00UKREGGenmab A/S Genmab To Hold 2023 R&D Update And Ash Data..
09/12/202318:00UKREGGenmab A/S New Pivotal Data For Bispecific Antibody..
05/12/202323:26UKREGGenmab A/S Capital Increase In Genmab As A Result Of..
27/11/202313:00UKREGGenmab A/S Genmab Announces Positive Regulatory Updates For..
22/11/202308:00UKREGGenuit Group PLC Strategy Progress Update Notification
21/11/202322:45UKREGGenmab A/S Transactions With Shares And Linked Securities In..
21/11/202322:42UKREGGenmab A/S Grant Of Restricted Stock Units To Board Members..
15/11/202310:03ALNCNewsGenuit shares rise as annual profit predicted to exceed..
15/11/202308:00UKREGGenuit Group PLC Trading Update
09/11/202315:14UKREGGenmab A/S Major Shareholder Announcement
09/11/202311:08UKREGGenuit Group PLC Director Declaration
09/11/202311:00UKREGGenmab A/S Genmab To Present At Jefferies London Healthcare..
08/11/202317:09UKREGGenmab A/S Major Shareholder Announcement
07/11/202317:01UKREGGenmab A/S Genmab Announces Financial Results For The First..
02/11/202314:05UKREGGenmab A/S Genmab Announces Multiple Abstracts To Be..
02/11/202312:59UKREGGenuit Group PLC Director/PDMR Shareholding
01/11/202317:00UKREGGenuit Group PLC Block listing Interim Review
01/11/202311:58ALNCNewsIN BRIEF: Genuit confirms interim CFO Tim Pullen as..
01/11/202308:00UKREGGenuit Group PLC Directorate Change
25/10/202317:04UKREGGenuit Group PLC Director/PDMR Shareholding
22/10/202316:30UKREGGenmab A/S Tivdak(R) (tisotumab vedotin-tftv) Significantly..
17/10/202317:05UKREGGenuit Group PLC Director/PDMR Shareholding
17/10/202312:22UKREGGenmab A/S Genmab Announces Net Sales Of Darzalex(R)..
11/10/202316:25UKREGGenuit Group PLC Director/PDMR Shareholding
06/10/202316:59UKREGGenuit Group PLC Director/PDMR Shareholding
28/9/202320:38UKREGGenmab A/S Grant Of Restricted Stock Units And Warrants To..
25/9/202313:45UKREGGenmab A/S Genmab Announces European Commission Approval Of..
25/9/202311:55UKREGGenmab A/S Epkinlytm (epcoritamab) Approved By Japan..
12/9/202320:04UKREGGenmab A/S Capital Increase In Genmab As A Result Of..
11/9/202313:56UKREGGenuit Group PLC Director/PDMR Shareholding
04/9/202321:00UKREGGenmab A/S Genmab And Seagen Announce That Tivdak(R)..
01/9/202312:19ALNCNewsIN BRIEF: Genuit hires former Arm, IQE exec Tim Pullen as..
01/9/202311:24DJNGenuit Appoints Tim Pullen as Interim CFO
Apertura: 431,00 Min: 431,00 Max: 443,50
Chiusura: 436,50

La tua Cronologia

LSE
GEN
Genuit
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network